Understanding factors that help cancer patients quit smoking after treatment
A Prospective Study on the Factors Sustaining Tobacco Abstinence in Patients Treated With Radio-chemotherapy or Radiotherapy Alone for Head and Neck or Lung Cancer
Centre Oscar Lambret · NCT06910566
This study is trying to find out what helps cancer patients who have had treatment for head and neck or lung cancer to quit smoking and stay smoke-free for at least six months.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Oscar Lambret (other) |
| Locations | 1 site (Lille) |
| Trial ID | NCT06910566 on ClinicalTrials.gov |
What this trial studies
The TABAC STOP ORL POUMON study evaluates the factors influencing long-term smoking cessation in patients with head and neck or lung cancer undergoing radiotherapy or chemoradiotherapy. This single-center observational study follows patients at 1, 6, and 12 months post-treatment, assessing their smoking status and various factors related to nicotine dependence. The primary goal is to determine the proportion of patients who remain smoke-free at 6 months, while secondary objectives explore reasons for relapse and changes in dependence levels. A total of 100 patients will be enrolled to ensure robust statistical analysis.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older diagnosed with head and neck or lung cancer who are current or former smokers undergoing curative treatment.
Not a fit: Patients receiving palliative treatment or those under guardianship may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into effective strategies for smoking cessation among cancer patients, potentially improving their overall health outcomes.
How similar studies have performed: Other studies have shown success in understanding smoking cessation in cancer patients, making this approach both relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria : * Patient aged 18 years or older * Diagnosed with head and neck cancer or lung cancer * Undergoing curative treatment with chemoradiotherapy, radiotherapy alone, or stereotactic radiotherapy * Current or former smoker * Patient covered by a social security scheme * Patient informed and having given consent for data collection Patients with human papillomavirus (HPV) may also be included Exclusion Criteria : * Patient receiving palliative treatment * Patient under guardianship or curatorship Study Exit Criteria : - Protocol-defined exit : After the 12-month consultation Early exit : * Withdrawal of consent for data collection * Death of the patient
Where this trial is running
Lille
- Centre Oscar Lambret — Lille, France (RECRUITING)
Study contacts
- Study coordinator: Fanny BEN OUNE
- Email: promotion@o-lambret.fr
- Phone: +33320295896
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Smoking Cessation, Nicotine Addiction, Nicotine Dependence, Smoking, Head and Neck Neoplasms, Tobacco abstinence, Head and neck cancer, Smoking cessation